Kunal D. Sutar, Rutika D. Harshad, Omkar S. Sangar, Aishwarya C. Patil, Santosh A. Payghan
Kunal D. Sutar*, Rutika D. Harshad*, Omkar S. Sangar, Aishwarya C. Patil, Santosh A. Payghan
Vasantidevi Patil Institute of Pharmacy, Kodoli MS.
Volume - 13,
Issue - 1,
Year - 2022
Stem cells are defined as strong clonogenic and regenerative cells and differentiate into multiple cell lines. Stem cells are found in all of us, from the earliest stages of human growth to the end of life. According to the classification of stem cells are divided into 5 types: totipotent, pluripotent, multipotent, oligopotent and unipotent. They are essential for growth, development, maintenance and repair of the brain, bones, muscles, nerves, blood, skin, and other organs. Stem cell therapy continues as a new flexible approach to the treatment of diseases and injuries, with extensive medical benefits. Stock research raises many ethical and scientific questions as well as future challenges. Stem cell therapy, a precursor to a period of cell-based treatment that will one day restore function to those whose lives are now facing the daily challenge, is on its way to recovery. Stem cells have great potential for tissue regeneration and tissue repair but much remains to be learned about their biology, deception and safety before their full therapeutic potential can be discovered. In today’s world, disease control is very exciting and new methods are available to provide quality patient care, on the basis of scientific experiments and practical studies conducted by various institutions and organizations. Mesenchymal stem cells (MSCs) are purchased from most body tissues usually by the placenta and umbilical cord but other sources such as bone marrow found in MSCs are also important as each source will give the cells their own characteristics. They can be used for a variety of heart-related problems, bacterial infections, cirrhosis, liver failure, diabetes, and cancer treatment. A variety of procedures, whether physical or surgical, are available including cell therapy, tissue, osteo-engineering engineering and immunosuppressive tests to treat disease and ensure complete recovery.
Cite this article:
Kunal D. Sutar, Rutika D. Harshad, Omkar S. Sangar, Aishwarya C. Patil, Santosh A. Payghan. An Overview of Stem Cell Therapy. Research Journal of Topical and Cosmetic Sciences. 2022; 13(1):21-6. doi: 10.52711/2321-5844.2022.00004
Kunal D. Sutar, Rutika D. Harshad, Omkar S. Sangar, Aishwarya C. Patil, Santosh A. Payghan. An Overview of Stem Cell Therapy. Research Journal of Topical and Cosmetic Sciences. 2022; 13(1):21-6. doi: 10.52711/2321-5844.2022.00004 Available on: https://rjtcsonline.com/AbstractView.aspx?PID=2022-13-1-4
1. Fact Sheet. what are Stem Cells Last updated: July 2010 [www.stemcellcentre.edu.au].
2. Kalra K and Tomar PC, Stem Cell: Basics, Classification and Applications. American Journal of Phytomedicine and Clinical Therapeutics, AJPC.2014; 2(7)91-930
3. International Society for Stem Cell Research, stem cell fact 2011[ http://www.isscr.org].
4. Friedenstein AJ, Piatetzky S II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966; 16:381–90.
5. Jesse.K. Biehi, B.S.and Brenda Russell. Introduction to Stem Cell”, J. Cardiovasc.Nurs.2009; 24(2):1-10.
6. Stem cell basic Last modified on April 08, 2015 [http://stemcells.nih.gov/info/].
7. S. Avasthi, R. N. Srivas tava, A. Singh and M. Srivastava ―Stem cells: Past, Present, Future –a review article‖, Internaet J. Med. Update, 2008, 3(1):22-30
9. Schöler HR, The Potential Of Stem Cells: An Inventory". In Nikolaus Knoepffler, Dagmar Schipanski, and Stefan Lorenz Sorgner. Humanbiotechnology as Social Challenge. Ashgate Publishing, Ltd. 2011; 1:380.
10. Hans R. The potential of stem cells: An inventory. Human biotechnology as Social Challenge, England, Ashgate Publishing, Ltd.2007; 28
12. I Singec, R. Jandial, A. Crain, G. Nikkhahand E.Y. Snyder, "The leading edge of stemcell therapeutics". Annu. Rev. Med. 58, 2007, 313–328.
13. C.R. Freed, P.E. Greene, R. E Breeze, W-Y Tsai, W. DuMoucel, R. Kao, S. Dillon, H. Winfield, S. Culver, J.Q. Trojanowski, D. Eidelberg and S. Fahn, “Transplantation of embryonic dopamine neurons for severe parkinson’s disease” New England J. of. Med., 344, 2000, 710-719.
14. WWW.Wikipedia.com accessed on: 25 Dec 2018).
15. Copeland N, Harris D, Gaballa MA: Human umbilical cord blood stem cells, myocardial infarction and stroke. Clin Med 2009, 9(4):342-345.
16. Wollert KC, Drexler H: Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol 2010, 7(4):204-215.
17. Ali H, Bahbahani H: Umbilical cord blood stem cells – potential therapeutic tool for neural injuries and disorders. Acta Neurobiol Exp (Wars) 2010, 70(3):316-324.
18. Basharut A. Syed and James B. Evans; Visiongain. Stem Cell Technologies: World Market Outlook 2012–2022 doi: 10.1038/nrd3953. Visiongain (2012).